Use of a Newly Developed Delivery Device for Percutaneous Introduction of Multiple Lead Configurations for Spinal Cord Stimulation. Issue 5 (25th February 2014)
- Record Type:
- Journal Article
- Title:
- Use of a Newly Developed Delivery Device for Percutaneous Introduction of Multiple Lead Configurations for Spinal Cord Stimulation. Issue 5 (25th February 2014)
- Main Title:
- Use of a Newly Developed Delivery Device for Percutaneous Introduction of Multiple Lead Configurations for Spinal Cord Stimulation
- Authors:
- Raso, Louis J.
Deer, Timothy R.
Schocket, Sandford M.
Chapman, Jack A.
Duarte, Luis E.
Justiz, Rafael
Amirdelfan, Kasra
Paicius, Richard M.
Navalgund, Yeshvant A.
Girardi, George E.
Coleman, Neal E.
Verdolin, Michael
Haider, Nameer
Rosen, Steven
Netherton, Mark D.
Owens, Michael Chad
Bennett, Matthew T.
Rosenberg, Jason
Jackson, Shaun
Nelson, Christopher L.
Davis, Timothy T. - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ner12138-sec-0001" sec-type="section"> <title>Objective</title> <p>The Epiducer lead delivery system is a novel lead delivery device that can be used to percutaneously implant S‐Series paddle leads (St. Jude Medical, Plano, TX, USA) as well as multiple percutaneous leads obviating the need for laminectomy and/or multiple needle sticks, respectively. This study evaluates the safety and usage of the Epiducer lead delivery system.</p> </sec> <sec id="ner12138-sec-0002" sec-type="section"> <title>Methods</title> <p>An Institutional Review Board‐approved observational data collection study was conducted to evaluate usage patterns of the Epiducer system. In addition to the number and frequency of different lead configurations, the following procedural aspects of the surgery were recorded during the evaluation: angle of entry, distance from entry to final lead placement, and physician feedback. Descriptive statistics on adverse events, procedural aspects, and patient outcomes were compiled.</p> </sec> <sec id="ner12138-sec-0003" sec-type="section"> <title>Results</title> <p>Data were collected from 163 patients across 25 investigational sites. Physicians successfully implanted patients using the Epiducer during 89% of the procedures. Seven possible lead configurations were implanted. There were 96% and 92% of physicians "satisfied" or "very satisfied" with accessing the epidural space and<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ner12138-sec-0001" sec-type="section"> <title>Objective</title> <p>The Epiducer lead delivery system is a novel lead delivery device that can be used to percutaneously implant S‐Series paddle leads (St. Jude Medical, Plano, TX, USA) as well as multiple percutaneous leads obviating the need for laminectomy and/or multiple needle sticks, respectively. This study evaluates the safety and usage of the Epiducer lead delivery system.</p> </sec> <sec id="ner12138-sec-0002" sec-type="section"> <title>Methods</title> <p>An Institutional Review Board‐approved observational data collection study was conducted to evaluate usage patterns of the Epiducer system. In addition to the number and frequency of different lead configurations, the following procedural aspects of the surgery were recorded during the evaluation: angle of entry, distance from entry to final lead placement, and physician feedback. Descriptive statistics on adverse events, procedural aspects, and patient outcomes were compiled.</p> </sec> <sec id="ner12138-sec-0003" sec-type="section"> <title>Results</title> <p>Data were collected from 163 patients across 25 investigational sites. Physicians successfully implanted patients using the Epiducer during 89% of the procedures. Seven possible lead configurations were implanted. There were 96% and 92% of physicians "satisfied" or "very satisfied" with accessing the epidural space and placing multiple leads with the Epiducer delivery system, respectfully. Eighty‐nine percent of physicians were "satisfied" or "very satisfied" with implanting an S‐Series paddle lead using the Epiducer delivery system. Ninety‐five percent of physicians were "satisfied" or "very satisfied" with the Epiducer delivery system overall. Ten patients (6%) experienced adverse events.</p> </sec> <sec id="ner12138-sec-0004" sec-type="section"> <title>Conclusion</title> <p>Results suggest that the Epiducer delivery system allows for the safe and successful percutaneous implantation of paddle leads and/or multiple lead configurations. Furthermore, physicians are satisfied with the Epiducer delivery system.</p> </sec> </abstract> … (more)
- Is Part Of:
- Neuromodulaton. Volume 17:Issue 5(2014)
- Journal:
- Neuromodulaton
- Issue:
- Volume 17:Issue 5(2014)
- Issue Display:
- Volume 17, Issue 5 (2014)
- Year:
- 2014
- Volume:
- 17
- Issue:
- 5
- Issue Sort Value:
- 2014-0017-0005-0000
- Page Start:
- 465
- Page End:
- 471
- Publication Date:
- 2014-02-25
- Subjects:
- Central nervous system -- Physiology -- Periodicals
Central nervous system -- Diseases -- Periodicals
616.8 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1525-1403 ↗
https://www.sciencedirect.com/journal/neuromodulation-technology-at-the-neural-interface ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/ner.12138 ↗
- Languages:
- English
- ISSNs:
- 1094-7159
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.504100
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3414.xml